Varughese J

No ORCID on file · 3 papers in corpus
2024
Case Series: Rare cystic variant of adenomatoid tumor of the uterus.
Gynecologic oncology reports ·doi:10.1016/j.gore.2024.101493
2020
Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics10020106

Ovarian cancer is one of the most lethal gynecological cancers in women due to late diagnosis. Despite technological advancements, experienced physicians have high sensitivities and specificities in subjective assessments when combining ult…

2011
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Clinical & experimental metastasis ·doi:10.1007/s10585-011-9401-0

We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease. We studied the expres…